3-(4-Amino-5-oxo-5H-chromeno[4,3-d]pyrimidin-2-yl)phenyl 4-(trifluoromethyl)benzenesulfonate

ID: ALA5272341

Max Phase: Preclinical

Molecular Formula: C24H14F3N3O5S

Molecular Weight: 513.45

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(-c2cccc(OS(=O)(=O)c3ccc(C(F)(F)F)cc3)c2)nc2c1c(=O)oc1ccccc12

Standard InChI:  InChI=1S/C24H14F3N3O5S/c25-24(26,27)14-8-10-16(11-9-14)36(32,33)35-15-5-3-4-13(12-15)22-29-20-17-6-1-2-7-18(17)34-23(31)19(20)21(28)30-22/h1-12H,(H2,28,29,30)

Standard InChI Key:  FYOCJUFRTJWOAT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   -3.2066    0.2069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4920    0.6192    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7801    0.2074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7801   -0.6178    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4902   -1.0296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2066   -0.6215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9221   -1.0340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6399   -0.6199    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6417    0.2044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9272    0.6227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9325    1.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6541    1.8591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3640    1.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3587    0.6132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9221   -1.8591    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4902   -1.8547    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0654    0.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0652    1.4452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3524    1.8557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3624    1.4431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3639    0.6220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3477    0.2054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0786    0.2095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7933    0.6220    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.5078    0.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2227    0.6219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9348    0.2099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9348   -0.6155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2245   -1.0274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5078   -0.6192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2065    1.3380    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3815    1.3380    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6495   -1.0281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3640   -0.6155    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.6495   -1.8533    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.3640   -1.4407    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  5  4  2  0
  6  5  1  0
  1  6  2  0
  6  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  2  0
  1 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  9 14  1  0
  7 15  2  0
  5 16  1  0
 17  3  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 29 28  1  0
 30 29  2  0
 25 30  1  0
 24 31  2  0
 24 32  2  0
 28 33  1  0
 33 34  1  0
 33 35  1  0
 33 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5272341

    ---

Associated Targets(Human)

CNE-2 (385 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAL-27 (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 513.45Molecular Weight (Monoisotopic): 513.0606AlogP: 4.77#Rotatable Bonds: 4
Polar Surface Area: 125.38Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.29CX LogP: 5.99CX LogD: 5.99
Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.21Np Likeness Score: -0.96

References

1. Lv N, Sun M, Liu C, Li J..  (2017)  Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.,  27  (19): [PMID:28888820] [10.1016/j.bmcl.2017.08.044]

Source